Change history
13 November 2020
The article “Boeszoermenyi A, Ogórek B, Jain A, Arthanari H, Wagner G (2020) The precious fluorine on the ring: fluorine NMR for biological systems. J Biomol NMR. https ://doi.org/10.1007/s10858-020-00331–z” was written for the “Special Issue: NMR in Pharmaceutical Discovery and Development”. However, unfortunately, it was published in an earlier issue of this journal owing to a publisher error. Further, the ORCID ID of author Wolfgang Jahnke is updated in the article. The original article has been corrected.
References
Boeszoermenyi A, Ogórek B, Jain A, Arthanari H, Wagner G (2020) The precious fluorine on the ring: fluorine NMR for biological systems. J Biomol NMR 74:365–379. https://doi.org/10.1007/s10858-020-00331-z
Brinson RG, Elliott KW, Arbogast LW, Sheen DA, Giddens JP, Marino JP, Delaglio F (2020) Principal component analysis for automated classification of 2D spectra and interferograms of protein therapeutics: influence of noise, reconstruction details, and data preparation. J Biomol NMR. https://doi.org/10.1007/s10858-020-00332-y
Casagrande F, Dégardin K, Ross A (2020) Protein NMR of biologicals: analytical support for development and marketed products. J Biomol NMR. https://doi.org/10.1007/s10858-020-00318-w
Dalvit C, Veronesi M, Vulpetti A (2020) Fluorine NMR functional screening: from purified enzymes to human intact living cells. J Biomol NMR. https://doi.org/10.1007/s10858-020-00311-3
Doak BC, Norton RS, Scanlon MJ (2016) The ways and means of fragment-based drug design. Pharmacol Ther 167:28–37
Dubey A, Takeuchi K, Reibarkh M, Arthanari H (2020) The role of NMR in leveraging dynamics and entropy in drug design. J Biomol NMR. https://doi.org/10.1007/s10858-020-00335-9
Erlanson DA (2020) https://practicalfragments.blogspot.com/2020/03/fragments-in-clinic-2020-edition.html.
Erlanson DA, Davis BJ, Jahnke W (2019) Fragment-based drug discovery: advancing fragments in the absence of crystal structures. Cell Chem Biol 26:9–15
Erlanson DA, de Esch IJP, Jahnke W, Johnson CN, Mortenson PN (2020) Fragment-to-lead medicinal chemistry publications in 2018. J Med Chem 63:4430–4444
Hanzawa H, Shimada T, Takahashi M, Takahashi H (2020) Revisiting biomolecular NMR spectroscopy for promoting small-molecule drug discovery. J Biomol NMR. https://doi.org/10.1007/s10858-020-00314-0
Horst R, Farley KA, Kormos BL, Withka JM (2020) NMR spectroscopy: the Swiss army knife of drug discovery. J Biomol NMR. https://doi.org/10.1007/s10858-020-00330-0
Keiffer S, Carneiro MG, Hollander J, Kobayashi M, Pogoryelev D, Eiso AB, Theisgen S, Müller G, Siegal G (2020) NMR in target driven drug discovery: why not? J Biomol NMR. https://doi.org/10.1007/s10858-020-00343-9
Marshall CB, KleinJan F, Gebregiworgis T, Lee K-Y, Fang Z, Eves BJ, Liu NF, Gasmi-Seabrook GMC, Enomoto M, Ikura M (2020) NMR in integrated biophysical drug discovery for RAS: past, present, and future. J Biomol NMR. https://doi.org/10.1007/s10858-020-00338-6
Mureddu LG, Ragan TJ, Brooksbank EJ, Vuister GW (2020) CcpNmr AnalysisScreen, a new software programme with dedicated automated analysis tools for fragment-based drug discovery by NMR. J Biomol NMR. https://doi.org/10.1007/s10858-020-00321-1
Nebl S, Alwan WS, Williams ML, Sharma G, Taylor A, Doak BC, Wilde KL, McMahon RM, Halili MA, Martin JL, Capuano B, Fenwick RB, Mohanty B, Scanlon MJ (2020) NMR fragment screening reveals a novel small molecule binding site near the catalytic surface of the disulfide-dithiol oxidoreductase enzyme DsbA from Burkholderia pseudomallei. J Biomol NMR. https://doi.org/10.1007/s10858-020-00339-5
Orts J, Riek R (2020) Protein-ligand structure determination with the NMR molecular replacement tool, NMR2. J Biomol NMR. https://doi.org/10.1007/s10858-020-00324-y
Rüdisser SH, Goldberg N, Ebert MO, Kovacs H, Gossert AD (2020) Efficient affinity ranking of fluorinated ligands by 19F NMR: CSAR and FastCSAR. J Biomol NMR. https://doi.org/10.1007/s10858-020-00325-x
Softley CA, Bostock MJ, Popowicz GM, Sattler M (2020) Paramagnetic NMR in drug discovery. J Biomol NMR 74:287–309
Sreeramulu S, Richter C, Kuehn T, Azzaoui K, Blommers MJJ, Del Conte R, Fragai M, Trieloff N, Schmieder P, Nazare M, Specker E, Ivanov V, Oschkinat H, Banci L, Schwalbe H (2020) NMR quality control of fragment libraries for screening. J Biomol NMR. https://doi.org/10.1007/s10858-020-00327-9
Urquhart L (2020a) FDA new drug approvals in Q1 2020. Nat Rev Drug Discov 19:299
Urquhart L (2020b) FDA new drug approvals in Q2 2020. Nat Rev Drug Discov 19:503
Author information
Authors and Affiliations
Corresponding authors
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
The original online version of this article was revised: The article Boeszoermenyi A, Ogórek B, Jain A, Arthanari H, Wagner G (2020) The precious fluorine on the ring: fluorine NMR for biological systems. J Biomol NMR. https://doi.org/10.1007/s10858-020-00331-z was written for the Special Issue: NMR in Pharmaceutical Discovery and Development. However, unfortunately, it was published in an earlier issue of this journal owing to a publisher error. Further, the ORCID ID of author Wolfgang Jahnke is updated in the article.
Rights and permissions
About this article
Cite this article
Norton, R.S., Jahnke, W. NMR in pharmaceutical discovery and development. J Biomol NMR 74, 473–476 (2020). https://doi.org/10.1007/s10858-020-00345-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10858-020-00345-7